The sleep and neurodiagnostic company SOMNOmedics GmbH received US Food & Drug Administration (FDA) approval for the pediatric use of its polysomnography systems SOMNOscreen HD, SOMNOscreen plus, and SOMNOscreen Eco in August 2020. The FDA approval is for children as young as 2 years old. Features include: Wide range of pediatric sensors available. Specific analysis templates for children available in DOMINO software. Wireless data transfer in real time. High sampling rate and short cables with active sensors. 24/7 service support included. Simultaneous data recording to the internal memory card. Interface for integration of external devices. Many built in sensors means fewer cables.